Transcranial Magnetic Stimulation (TMS) acts as an FDA-sanctioned option for adults experiencing major depressive disorder who have not responded well to antidepressants. This clinic-based approach uses magnetic impulses directed at the prefrontal area of the brain. On average, patients require 20 to 30 sessions to alleviate depression, spread across 4 to 6 weeks. The procedure lasts approximately 20 minutes, presents few side effects, and allows individuals to return to their normal routines, such as employment or education. In contrast to pharmaceuticals, TMS offers very few unwanted effects.
Data Unavailable
Transcranial Magnetic Stimulation (TMS) functions as an FDA-authorized intervention for adults with major depressive disorder who have not gained relief from antidepressants. This office-delivered process utilizes magnetic pulses aimed at the prefrontal cortex in the brain. Typically, patients undergo 20 to 30 treatments to move past depression, occurring over 4 to 6 weeks. Each treatment session extends about 20 minutes, includes minimal side effects, and permits individuals to proceed with their daily lives, including work or school. Unlike traditional medications, TMS is characterized by very few side effects.